Phenytoin-Induced Gingival Overgrowth: A Review
Author Information
Author(s): Corrêa Jôice Dias, Queiroz-Junior Celso Martins, Costa José Eustáquio, Teixeira Antônio Lúcio, Silva Tarcilia Aparecida
Primary Institution: Federal University of Minas Gerais
Hypothesis
The study aims to review the molecular, immune, and inflammatory aspects of phenytoin-induced gingival overgrowth.
Conclusion
Phenytoin-induced gingival overgrowth involves a decrease in collagen degradation related to alterations in calcium metabolism and levels of various proteins.
Supporting Evidence
- Phenytoin is one of the most commonly prescribed medications for epilepsy.
- 30 to 50% of patients taking phenytoin develop significant gingival alterations.
- Drug-induced gingival overgrowth is influenced by the accumulation of dental plaque.
Takeaway
Some medicines can make your gums grow too big, and this study looks at why that happens when people take phenytoin.
Methodology
The paper reviews various studies on the mechanisms and factors involved in phenytoin-induced gingival overgrowth.
Limitations
The mechanisms of drug-induced gingival overgrowth are not fully understood and existing studies show contradictory results.
Participant Demographics
The condition seems to be more prevalent in children and teenagers, with no significant differences in incidence based on gender or ethnicity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website